Ben Botkin

Oregon Bill Would Boost Market Access To Generic Prescription Drugs 

This article is for premium subscribers. Please sign up here for a tax-deductible subscription. 

If you're a premium subscriber, sign in below. 

Senate Bill 764 would prevent "pay to delay" agreements between pharmaceutical companies that delay the introduction of generic prescription drugs into the market.

Oregon Could Receive 25,000 Doses Of Johnson & Johnson Vaccine Next Week

This article is for premium subscribers. Please sign up here for a tax-deductible subscription. 

If you're a premium subscriber, sign in below. 

Patrick Allen, director of the Oregon Health Authority, said the initial shipment is likely to be the biggest as the company dives into its stockpile and then tries to ramp up production.

Pages

Subscribe to Ben Botkin